Grahame Elder





Renal Medicine



Areas of Interest

Bone and mineral metabolism, kidney disease, dialysis and transplantation


028890 6962

Fax: 9633 9351


Clinical Professor University of Notre Dame Australia and Associate Professor University of Sydney 


Visiting Medical Officer (VMO)


  • Rajkumar T, Mazid S, Vucak-Dzumhur M, Sykes TM, Elder GJ. Health related quality of life following kidney and simultaneous pancreas kidney transplantation. Nephrology (Carlton). 2019 Sep;24(9):975-982.
  • Lioufas N, Toussaint ND, Pedagogos E, Elder GJ, Badve S, Pascoe EM, Valks A, Hawley C. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? - Rationale and protocol for the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study. BMJ Open 2019 Feb 21;9(2)
  • Lewis JR, Wong G, Taverniti A, Vucak-Dzumhur M, Elder GJ. Association between aortic calcification, cardiovascular events and mortality in kidney and pancreas-kidney transplant recipients. American Journal of Nephrology 2019 Aug 8:1-10
  •  Aleksova J, Milat F, Kotowicz M, Pasco J, Schultz C, Wong P, Ebeling, Elder GJ. Patients with End Stage Kidney Disease have Markedly Abnormal Cortical Hip Parameters by Dual-Energy X-ray Absorptiometry. Nephrology Dialysis Transplant 7 November 2019
  •  Ruderman I, Toussaint ND, Hawley CM, Krishnasamy R, Pedagogos E, Lioufas N, Elder GJ. The Australian Calciphylaxis Registry – reporting clinical features and outcomes of patients with calciphylaxis. Nephrol Dialysis Transplant 19 December 2019
  • Toussaint ND, Lioufas I, Pedagogos E, Hawley C (Co-author), Pascoe E, Elder GJ, Badve S, Valks A. Aortic calcification and arterial stiffness burden in a CKD cohort with high CV risk: Baseline characteristics of the IMpact of Phosphate Reduction On Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) trial. Am J Nephrol 2020
  •  Conley M, Lioufas I, Toussaint ND, Pedagogos E, Elder  GJ, Badve SV, Hawley CM, Pascoe E, Valks A, Campbell KL. Dietary phosphate consumption in Australians with stages 3b and 4 chronic kidney disease. J Renal Nutrition 2020